Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15536700 | 0.93 | ALDH1A1 (0.47) | TSHRTHRBHCAR2ALDH1A1GAA | |
| SCHEMBL6657193 | 0.91 | TSHR (0.42) | TSHRTHRBHCAR2ALDH1A1GAA | |
| SCHEMBL629109 | 0.88 | TSHR (0.44) | TSHRTHRBHCAR2ALDH1A1GAA | |
| SCHEMBL5408195 | 0.88 | TSHR (0.48) | TSHRTHRBHCAR2ALDH1A1GAA | |
| SCHEMBL21802370 | 0.87 | TSHR (0.69) | TSHRHCAR2ALDH1A1LMNARAD52 | |
| SCHEMBL18499281 | 0.85 | TSHR (0.56) | TSHRTHRBALDH1A1MAPTRAD52 | |
| SCHEMBL5871854 | 0.85 | TSHR (0.61) | TSHRTHRBHCAR2ALDH1A1SMN1; SMN2 | |
| SCHEMBL5871624 | 0.83 | TSHR (0.70) | TSHRHCAR2ALDH1A1LMNAHPGD | |
| SCHEMBL138475 | 0.83 | HCAR2 (0.48) | TSHRTHRBHCAR2ALDH1A1GAA | |
| SCHEMBL45789 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119552307-A | Preparation method of ester modified SBC carbon five petroleum resin | 恒河材料科技股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| EP-3865520-B1 | CURING AGENT COMPOSITION FOR CURING 2-METHYLENE-1,3-DICARBONYL COMPOUND | NAMICS CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-113249041-B | Resin composition | 纳美仕有限公司 | 2023-08-15 | — | — | CN | disclosed |
| EP-3626751-B1 | RESIN COMPOSITION | NAMICS CORP (JP) | 2023-05-17 | — | — | EP | disclosed |
| US-11634615-B2 | Resin composition | NAMICS CORPORATION (JP) | 2023-04-25 | — | — | US | disclosed |
| CN-112789299-B | Curing agent composition for curing 2-methylene-1, 3-dicarbonyl compounds | 纳美仕有限公司 | 2023-02-21 | — | — | CN | disclosed |
| CN-114341215-A | Curable composition | 株式会社日本触媒 | 2022-04-12 | — | — | CN | disclosed |
| US-20220089504-A1 | Curing Agent, Method for Producing Cement Structure with Coating Film, Shrinkage Reduction Method and Drying Suppression Method for Cement Molded Body, and Method for Suppressing Penetration of Deterioration Factor into Cement Structure | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-03-24 | — | — | US | disclosed |
| CN-111278869-B | Resin composition | 纳美仕有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-11230617-B2 | Resin composition | NAMICS CORPORATION (JP) | 2022-01-25 | — | — | US | disclosed |
| US-7071187-B2 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2006-07-04 | — | — | US | disclosed |
| US-20040214853-A1 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-10-28 | — | — | US | disclosed |
| EP-1123915-B1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | NIPPON CATALYTIC CHEM IND (JP) | 2004-07-28 | — | — | EP | disclosed |
| EP-1426374-A1 | NAPHTHYRIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-6541656-B2 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY, LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20010034300-A1 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1123915-A1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | Nippon Shokubai Co., Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
| EP-0102404-A1 | Novel polycyclic fused pyrazole compounds useful as antiinflammatory agents and preparation thereof | STERLING DRUG INC. (US) | 1984-03-14 | — | — | EP | disclosed |
| US-4349558-A | Anti-inflammatory 8H-phenanthro-[2,3-c]pyrazole derivatives | STERLING DRUG INC. (US) | 1982-09-14 | — | — | US | disclosed |
| US-4056543-A | FROM A SUBSTITUTED NORBORNENE AND A HALOFORMATE, ALKYLLITHIUM AMIDE CATALYST | EASTMAN KODAK COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089504-A1 | Curing Agent, Method for Producing Cement Structure with Coating Film, Shrinkage Reduction Method and Drying Suppression Method for Cement Molded Body, and Method for Suppressing Penetration of Deterioration Factor into Cement Structure | WDR1, WDR82, CECR2 | TSHR 3849/4885THRB 2568/4885HCAR2 519/4885 |
| US-20040214853-A1 | Naphthyridine derivatives | MT-ND1, OPRD1, NR0B1 | TSHR 2365/4885THRB 3266/4885HCAR2 2731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.